Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Henrik Johansson

Karolinska Institutet

Sweden

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

80%

Biochemistry

60%

Cancer Biology

60%

Dna Methylation

30%

Metabolic Biology

30%

Tumorigenesis

30%

Nutrigenomics

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Mechanical control of breast cancer malignancy by promotion of mevalonate pathway enzyme synthesis

Article Link

Year:

2025

The DNA methylation landscape of primary triple-negative breast cancer

Article Link

Year:

2025

SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.

Article Link

Year:

2024

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

Article Link

Year:

2024

Fine Tuning of Phosphorothioate Inclusion in 2′-O-Methyl Oligonucleotides Contributes to Specific Cell Targeting for Splice-Switching Modulation

Article Link

Year:

2021

Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Article Link

Year:

2021

Correcting for Naturally Occurring Mass Isotopologue Abundances in Stable-Isotope Tracing Experiments with PolyMID

Article Link

Year:

2021

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation

Article Link

Year:

2021

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer

Article Link

Year:

2020

Combined transcriptome and proteome profiling of the pancreatic β-cell response to palmitate unveils key pathways of β-cell lipotoxicity.

Article Link

Year:

2020

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.

Article Link

Year:

2020

Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy

Article Link

Year:

2020

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.

Article Link

Year:

2020

Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC.

Article Link

Year:

2020

Collaborators17

Johan Vallon-Christersson

Lund University

SWEDEN

Olena Berkovska

Karolinska Institutet

SWEDEN

Elsa Arbajian

SWEDEN

Andrä Brunner

Karolinska Institutet

SWEDEN

Ingrid Hedenfalk

Lund University

SWEDEN

Cristina Rocha

Professor Adjunto Convidado

Polytechnic Institute of Porto

PORTUGAL

Janne Lehtiö

Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN

Nathaniel Vacanti

Assistant Professor of Molecular Nutrition

Cornell University

UNITED STATES

Ioannis Zerdes

Karolinska University Hospital

SWEDEN

Lukas Orre

Karolinska University Hospital

SWEDEN

ANTHONY PIRON

Université libre de Bruxelles (ULB)

BELGIUM

Magali Merrien

Karolinska Institutet

SWEDEN

Birgitta Sander

SWEDEN

Mariana Igoillo-Esteve

Université libre de Bruxelles (ULB)

BELGIUM

Malin Wickström

Karolinska University Hospital

SWEDEN

Dhifaf Sarhan

Associate Professor

Karolinska Institutet

SWEDEN

Artur Mezheyeuski

Uppsala University

SWEDEN

How do I reach out?

Meet Kite AI